At the beginning of the February, Johnson & Johnson Vision, a global leader in eye health, announced that the FDA approved the TECNIS EyhanceTM and TECNIS EyhanceTM Toric II intraocular lens (IOL) for the treatment of cataract patients in the United States. Dr. Farhan Irshad and the Eye Clinic of Austin team were the first […]
Just a few months ago, Alcon, a leader in global eye care, announced the launch of a new and innovative intraocular lens (IOL) called AcrySof® IQ Vivity®. The Vivity lens is a first-of-its-kind and first unrolled in Europe in early 2020 following in North America only recently. During this time, the Eye Clinic of Austin’s […]
Are you tired of trying to remember to use your prescribed topical eye drops or not a fan of the side effects? If you’re suffering from elevated eye pressure we have good news! A breakthrough treatment called DURYSTA™ is now being used and can replace your eyedrops to help keep your eye pressure under control, […]
In the past few months, Eye Clinic of Austin has unveiled new treatment offerings for our patients.
The FDA has approved AcrySof IQ PanOptix Trifocal IOL, the first and only trifocal lens authorized for patients undergoing cataract surgery.
Dr. Farhan Irshad was the first anterior segment surgeon in Texas to do the DEXTENZA implant for ocular pain following eye surgery.